The legislature finds
that:
(1) The health care system in the nation and in Washington
state costs nearly twice as much per capita as other
industrialized nations.
(2) The fragmentation and variation in administrative
processes prevalent in our health care system contribute to the
high cost of health care, putting it increasingly beyond the
reach of small businesses and individuals in Washington.
(3) In 2006, the legislature's blue ribbon commission on
health care costs and access requested the office of the
insurance commissioner to conduct a study of administrative costs
and recommendations to reduce those costs. Findings in the
report included:
(a) In Washington state approximately thirty cents of every
dollar received by hospitals and doctors' offices is consumed by
the administrative expenses of public and private payors and the
providers;
(b) Before the doctors and hospitals receive the funds for
delivering the care, approximately fourteen percent of the
insurance premium has already been consumed by payor
administration. The payor's portion of expense totals
approximately four hundred fifty dollars per insurance member per
year in Washington state;
(c) Over thirteen percent of every dollar received by a
physician's office is devoted to interactions between the
provider and payor;
(d) Between 1997 and 2005, billing and insurance related
costs for hospitals in Washington grew at an average pace of
nineteen percent per year; and
(e) The greatest opportunity for improved efficiency and
administrative cost reduction in our health care system would
involve standardizing and streamlining activities between
providers and payors.
(4) To address these inefficiencies, constrain health care
inflation, and make health care more affordable for
Washingtonians, the legislature seeks to establish streamlined
and uniform procedures for payors and providers of health care
services in the state. It is the intent of the legislature to
foster a continuous quality improvement cycle to simplify health
care administration. This process should involve leadership in
the health care industry and health care purchasers, with
regulatory oversight from the office of the insurance
commissioner.
[2009 c 298 § 1.]